Eugit Therapeutics YC Application

Summer 2022Active

Eugit Therapeutics went through Y Combinator in the Summer 2022 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Summer 2022
Industry: HealthcareTherapeutics
Team size: 2
Status: Active
Launched: 2022

Founders

Nizar BatadaFounder

What Eugit Therapeutics does

Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).

Eugit Therapeutics's YC application, reconstructed

Y Combinator application

Eugit Therapeutics, Summer 2022 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Eugit Therapeutics

Describe what your company does in 50 characters or less.

Enabling Tissue Targeting of Therapies

What is your company going to make? Please describe your product and what it does or will do.

We are building TAGHOME, a platform that uses T cell receptors to deliver drugs precisely to diseased tissues. This targets tissue-specific inflammatory diseases, aiming to improve safety and efficacy by reducing off-target toxicity. Our initial focus is on Inflammatory Bowel Disease patients in the U.S.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco and South San Francisco, CA, and will be based there after YC.

Explain your decision regarding location.

San Francisco is a biotech and synthetic biology hub with access to expertise and partners necessary for our therapeutic development. Being local makes clinical partnerships and team collaboration easier.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Eugit Therapeutics YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Eugit Therapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Eugit Therapeutics would present itself to YC, not the text they submitted.